BACHEM HOLDING AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.48 CHF | +0.28% |
|
+2.78% | +25.00% |
| Mar. 07 | Switzerland's Bachem Reports Improved FY23 Net Income, Sales | MT |
| Mar. 07 | Transcript : Bachem Holding AG, 2023 Earnings Call, Mar 07, 2024 |
Presenter SpeechNikki Parsons (Executives)Hello, and welcome to the media and analyst conferen...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Calendar
2024-05-13
- TIDES USA Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
6
Last Close Price
81.25
CHF
Average target price
70.8
CHF
Spread / Average Target
-12.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.00% | 6.72B | |
| +23.37% | 47.02B | |
| +48.83% | 41.86B | |
| -0.94% | 41.76B | |
| -5.86% | 28.8B | |
| +11.29% | 26.05B | |
| -20.92% | 19.15B | |
| +3.20% | 12.55B | |
| -2.67% | 11.82B | |
| +30.23% | 12.34B |
- Stock Market
- Equities
- BANB Stock
- News Bachem Holding AG
- Transcript : Bachem Holding AG, 2020 Earnings Call, Mar 12, 2021